232 related articles for article (PubMed ID: 20556203)
1. The role of sphingolipids and ceramide in pulmonary inflammation in cystic fibrosis.
Becker KA; Riethmüller J; Zhang Y; Gulbins E
Open Respir Med J; 2010 Mar; 4():39-47. PubMed ID: 20556203
[TBL] [Abstract][Full Text] [Related]
2. Ceramide in Pseudomonas aeruginosa infections and cystic fibrosis.
Becker KA; Grassmé H; Zhang Y; Gulbins E
Cell Physiol Biochem; 2010; 26(1):57-66. PubMed ID: 20502005
[TBL] [Abstract][Full Text] [Related]
3. Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis.
Teichgräber V; Ulrich M; Endlich N; Riethmüller J; Wilker B; De Oliveira-Munding CC; van Heeckeren AM; Barr ML; von Kürthy G; Schmid KW; Weller M; Tümmler B; Lang F; Grassme H; Döring G; Gulbins E
Nat Med; 2008 Apr; 14(4):382-91. PubMed ID: 18376404
[TBL] [Abstract][Full Text] [Related]
4. Accumulation of ceramide in the trachea and intestine of cystic fibrosis mice causes inflammation and cell death.
Becker KA; Tümmler B; Gulbins E; Grassmé H
Biochem Biophys Res Commun; 2010 Dec; 403(3-4):368-74. PubMed ID: 21078296
[TBL] [Abstract][Full Text] [Related]
5. Sphingolipids as targets for inhalation treatment of cystic fibrosis.
Becker KA; Riethmüller J; Seitz AP; Gardner A; Boudreau R; Kamler M; Kleuser B; Schuchman E; Caldwell CC; Edwards MJ; Grassmé H; Brodlie M; Gulbins E
Adv Drug Deliv Rev; 2018 Aug; 133():66-75. PubMed ID: 29698625
[TBL] [Abstract][Full Text] [Related]
6. Ceramide in cystic fibrosis.
Grassmé H; Riethmüller J; Gulbins E
Handb Exp Pharmacol; 2013; (216):265-74. PubMed ID: 23563661
[TBL] [Abstract][Full Text] [Related]
7. Acid sphingomyelinase inhibitors normalize pulmonary ceramide and inflammation in cystic fibrosis.
Becker KA; Riethmüller J; Lüth A; Döring G; Kleuser B; Gulbins E
Am J Respir Cell Mol Biol; 2010 Jun; 42(6):716-24. PubMed ID: 19635928
[TBL] [Abstract][Full Text] [Related]
8. Role of CD95 in pulmonary inflammation and infection in cystic fibrosis.
Becker KA; Henry B; Ziobro R; Tümmler B; Gulbins E; Grassmé H
J Mol Med (Berl); 2012 Sep; 90(9):1011-23. PubMed ID: 22314624
[TBL] [Abstract][Full Text] [Related]
9. Ceramide is increased in the lower airway epithelium of people with advanced cystic fibrosis lung disease.
Brodlie M; McKean MC; Johnson GE; Gray J; Fisher AJ; Corris PA; Lordan JL; Ward C
Am J Respir Crit Care Med; 2010 Aug; 182(3):369-75. PubMed ID: 20395562
[TBL] [Abstract][Full Text] [Related]
10. Invariant natural killer T (iNKT) cells prevent autoimmunity, but induce pulmonary inflammation in cystic fibrosis.
Siegmann N; Worbs D; Effinger F; Bormann T; Gebhardt M; Ulrich M; Wermeling F; Müller-Hermelink E; Biedermann T; Tighe M; Edwards MJ; Caldwell C; Leadbetter E; Karlsson MC; Becker KA; Gulbins E; Döring G
Cell Physiol Biochem; 2014; 34(1):56-70. PubMed ID: 24977481
[TBL] [Abstract][Full Text] [Related]
11. CFTR-dependent susceptibility of the cystic fibrosis-host to Pseudomonas aeruginosa.
Grassmé H; Becker KA; Zhang Y; Gulbins E
Int J Med Microbiol; 2010 Dec; 300(8):578-83. PubMed ID: 20951085
[TBL] [Abstract][Full Text] [Related]
12. Evidence for the Involvement of Lipid Rafts and Plasma Membrane Sphingolipid Hydrolases in
Schiumarini D; Loberto N; Mancini G; Bassi R; Giussani P; Chiricozzi E; Samarani M; Munari S; Tamanini A; Cabrini G; Lippi G; Dechecchi MC; Sonnino S; Aureli M
Mediators Inflamm; 2017; 2017():1730245. PubMed ID: 29333001
[TBL] [Abstract][Full Text] [Related]
13. Ceramide and sphingosine in pulmonary infections.
Seitz AP; Grassmé H; Edwards MJ; Pewzner-Jung Y; Gulbins E
Biol Chem; 2015 Jun; 396(6-7):611-20. PubMed ID: 25720061
[TBL] [Abstract][Full Text] [Related]
14. Recombinant Acid Ceramidase Reduces Inflammation and Infection in Cystic Fibrosis.
Gardner AI; Haq IJ; Simpson AJ; Becker KA; Gallagher J; Saint-Criq V; Verdon B; Mavin E; Trigg A; Gray MA; Koulman A; McDonnell MJ; Fisher AJ; Kramer EL; Clancy JP; Ward C; Schuchman EH; Gulbins E; Brodlie M
Am J Respir Crit Care Med; 2020 Oct; 202(8):1133-1145. PubMed ID: 32569477
[No Abstract] [Full Text] [Related]
15. Ceramide mediates lung fibrosis in cystic fibrosis.
Ziobro R; Henry B; Edwards MJ; Lentsch AB; Gulbins E
Biochem Biophys Res Commun; 2013 May; 434(4):705-9. PubMed ID: 23523785
[TBL] [Abstract][Full Text] [Related]
16. Defective acid sphingomyelinase pathway with Pseudomonas aeruginosa infection in cystic fibrosis.
Yu H; Zeidan YH; Wu BX; Jenkins RW; Flotte TR; Hannun YA; Virella-Lowell I
Am J Respir Cell Mol Biol; 2009 Sep; 41(3):367-75. PubMed ID: 19168701
[TBL] [Abstract][Full Text] [Related]
17. Glucosylceramide Critically Contributes to the Host Defense of Cystic Fibrosis Lungs.
Kovacic B; Sehl C; Wilker B; Kamler M; Gulbins E; Becker KA
Cell Physiol Biochem; 2017; 41(3):1208-1218. PubMed ID: 28427052
[TBL] [Abstract][Full Text] [Related]
18. Lipids in cystic fibrosis.
Becker KA; Henry B; Ziobro R; Riethmüller J; Gulbins E
Expert Rev Respir Med; 2011 Aug; 5(4):527-35. PubMed ID: 21859272
[TBL] [Abstract][Full Text] [Related]
19. Fenretinide corrects newly found ceramide deficiency in cystic fibrosis.
Guilbault C; De Sanctis JB; Wojewodka G; Saeed Z; Lachance C; Skinner TA; Vilela RM; Kubow S; Lands LC; Hajduch M; Matouk E; Radzioch D
Am J Respir Cell Mol Biol; 2008 Jan; 38(1):47-56. PubMed ID: 17656682
[TBL] [Abstract][Full Text] [Related]
20. Regulation of the inflammasome by ceramide in cystic fibrosis lungs.
Grassmé H; Carpinteiro A; Edwards MJ; Gulbins E; Becker KA
Cell Physiol Biochem; 2014; 34(1):45-55. PubMed ID: 24977480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]